SCHEMBL6537560

SCHEMBL6537560

Cc1cc(N)c2nccc(Cl)c2c1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD44 P16070 1/20 0.39
NR4A2 P43354 4/20 0.39
MMP14 P50281 1/20 0.38
CYP3A4 P08684 3/20 0.37
NOS3 P29474 3/20 0.37
NOS2 P35228 3/20 0.37
G6PD P11413 1/20 0.36
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
CCR1 P32246 1/20 0.34
CCR5 P51681 1/20 0.34
CCR8 P51685 1/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
NPC1 O15118 2/20 0.34
ATM Q13315 1/20 0.34
KDM4E B2RXH2 1/20 0.33
NOS1 P29475 1/20 0.33
ALDH1A1 P00352 1/20 0.33
PRMT5 O14744 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537500 0.79 NR4A2 (0.41) CD44NR4A2MMP14CYP3A4NOS3
SCHEMBL31565251 0.74 NR4A2 (0.46) NR4A2MMP14CYP3A4TSHRMAPK1
SCHEMBL6537373 0.74 NR4A2 (0.46) NR4A2MMP14CYP3A4TSHRMAPK1
SCHEMBL6538008 0.73 MEN1 (0.49) CYP3A4TSHRMAPK1MEN1KMT2A
SCHEMBL6537871 0.70 NR4A2 (0.43) NR4A2MMP14CYP3A4NOS3NOS2
SCHEMBL6971396 0.69 NOS2 (0.45) CYP3A4NOS3NOS2TSHRMAPK1
SCHEMBL5447339 0.68 HSP90AA1 (0.59) MMP14NOS3NOS2G6PDCCR1
SCHEMBL6537949 0.68 G6PD (0.44) NR4A2MMP14CYP3A4G6PDTSHR
SCHEMBL8112332 0.67 MEN1 (0.49) CYP3A4TSHRMAPK1MEN1KMT2A
SCHEMBL14389206 0.67 NSD2 (0.47) CYP3A4NOS3NOS2G6PDCCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed